XML 43 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements Of Earnings - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 22,595 $ 20,498 $ 18,449
Cost of sales 8,155 7,440 6,871
Gross profit 14,440 13,058 11,578
Research, development and engineering expenses 1,466 1,388 1,454
Selling, general and administrative expenses 7,685 7,111 6,386
Amortization of intangible assets 623 635 627
Goodwill and other impairments 977 36 270
Total operating expenses 10,751 9,170 8,737
Operating income 3,689 3,888 2,841
Other income (expense), net (197) (215) (158)
Earnings before income taxes 3,492 3,673 2,683
Income taxes 499 508 325
Net earnings $ 2,993 $ 3,165 $ 2,358
Net earnings per share of common stock:      
Basic net earnings per share of common stock (in dollars per share) $ 7.86 $ 8.34 $ 6.23
Diluted net earnings per share of common stock (in dollars per share) $ 7.76 $ 8.25 $ 6.17
Weighted-average shares outstanding (in millions):      
Basic (in shares) 381.0 379.6 378.2
Effect of dilutive employee stock compensation (in shares) 4.6 4.1 4.0
Diluted (in shares) 385.6 383.7 382.2